NEUROCRINE UK LIMITED - READING
| Company Profile | Company Filings |
Overview
NEUROCRINE UK LIMITED is a Private Limited Company from READING UNITED KINGDOM and has the status: Active.
NEUROCRINE UK LIMITED was incorporated 2 years ago on 26/05/2022 and has the registered number: 14133552. The accounts status is DORMANT and accounts are next due on 30/09/2024.
NEUROCRINE UK LIMITED was incorporated 2 years ago on 26/05/2022 and has the registered number: 14133552. The accounts status is DORMANT and accounts are next due on 30/09/2024.
NEUROCRINE UK LIMITED - READING
This company is listed in the following categories:
74909 - Other professional, scientific and technical activities n.e.c.
74909 - Other professional, scientific and technical activities n.e.c.
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/07/2022 | 30/09/2024 |
Registered Office
R+
READING
BERKSHIRE
RG1 1AZ
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 25/05/2023 | 08/06/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| MR MATT ABERNETHY | Nov 1979 | American | Director | 2022-05-26 | CURRENT |
| MR DARIN LIPPOLDT | Aug 1965 | American | Director | 2022-05-26 | CURRENT |
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2024-05-21 | CURRENT | ||
| MR KEVIN GORMAN | Oct 1947 | American | Director | 2022-05-26 UNTIL 2023-08-30 | RESIGNED |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Neurocrine Biosciences, Inc. | 2022-05-26 | San Diego California |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| Dormant Company Accounts - NEUROCRINE UK LIMITED | 2023-12-22 | 31-07-2022 | £100 Cash £100 equity |